- Home
- CRAN vs SOPH Comparison
CRAN vs SOPH Comparison
Compare CRAN & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRAN | SOPH |
|---|---|---|
| Founded | 2025 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.3M | 462.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRAN | SOPH |
|---|---|---|
| Price | $10.14 | $6.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 124.5K | ★ 387.6K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $2.92 |
| 52 Week High | $10.21 | $6.50 |
Technical Indicators
Market Signals| Indicator | CRAN | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 51.80 | 72.62 |
| Support Level | $9.97 | $4.63 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.03 | 0.37 |
| MACD | -0.01 | 0.07 |
| Stochastic Oscillator | 30.00 | 87.71 |
Price Performance
Historical ComparisonAbout CRAN Crane Harbor Acquisition Corp. II Class A Ordinary Shares
Crane Harbor Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.